Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1979 Jan;41(1):89–98. doi: 10.1136/hrt.41.1.89

Electrophysiological effects of L 9394 (benzoyl-indolizine) in man.

A Waleffe, A Bordalo, P Bruninx, H J Wellens, H E Kulbertus
PMCID: PMC482015  PMID: 426960

Abstract

The electrophysiological effects of L 9394 (benzoyl-indolizine), a substance chemically related to amiodarone, but devoid of iodine atoms, were investigated by programmed electrical stimulation of the heart in 12 patients with various forms of tachycardia. Four subjects had electrocardiographic evidence of the WPW syndrome and episodes of circus movement tachycardia. Paroxysmal supraventricular tachycardia, confined to the atrioventricular (AV) node, was found in 3 patients. In 2 cases, where a short PR interval was present, the main complaint was the occurrence of paroxysmal atrial fibrillation. In the remaining 3 instances, the arrhythmia consisted of slow ventricular tachycardia (1 case), supraventricular tachycardia of the focal type (1 case), and episodes of primary ventricular fibrillation, not related to acute myocardial ischaemia (1 case). L 9394 injected intravenously was seen to lengthen the transnodal conduction time as well as the effective and functional refractory periods of the node. Similar effects were found on the retrograde VA pathway. The drug had no action on the infra-Hisian conduction system, on the refractory periods of ventricular muscle, or on the refractory periods of accessory bypasses. The drug was injected during an episode of tachycardia in 6 cases with reproducible supraventricular re-entrant tachycardia. Three had a tachycardia circuit confined to the node. In those instances, the drug had beneficial effects (slowing and interruption of tachycardia, decrease or abolition of echo zone; loss of ability to induce tachycardia). In the other 3 cases, an accessory pathway was incorporated in the circuit. L 9394 interrupted the tachycardia in 2 instances (by anterograde AV block), but failed to protect all 3 patients against reinitiation of tachycardia by premature stimuli. It is concluded that L9394 does not share all the pharmacological properties of amiodarone and will not replace it in all its indications.

Full text

PDF
89

Images in this article

92Image
on p.92
93Image
on p.93
94Image
on p.94
97Image
on p.97
97Image
on p.97

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Babel J., Stangos N. L'action de l'amiodarone sur les tissus oculaires. Schweiz Med Wochenschr. 1972 Feb 19;102(7):220–223. [PubMed] [Google Scholar]
  2. Berkman M., Benaim R., Chapelle M. Troubles de la conduction induits par l'amiodarone orale et injectable. Conséquences thérapeutiques. Coeur Med Interne. 1975 Jul-Sep;14(3):439–447. [PubMed] [Google Scholar]
  3. Burger A., Dinichert D., Nicod P., Jenny M., Lemarchand-Béraud T., Vallotton M. B. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxin, and thyrotropin. A drug influencing peripheral metabolism of thyroid hormones. J Clin Invest. 1976 Aug;58(2):255–259. doi: 10.1172/JCI108466. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coumel P., Fidelle J., Cloup M., Toumieux M. C., Attuel P. Les tachycardies réciproques à évolution prolongée chez l'enfant. Arch Mal Coeur Vaiss. 1974 Jan;67(1):23–38. [PubMed] [Google Scholar]
  5. Geerts M. L. Amiodarone pigmentation. An electron microscopic study. Arch Belg Dermatol Syphiligr. 1971 Oct-Dec;27(4):339–351. [PubMed] [Google Scholar]
  6. Pritchard D. A., Singh B. N., Hurley P. J. Effects of amiodarone on thyroid function in patients with ischaemic heart disease. Br Heart J. 1975 Aug;37(8):856–860. doi: 10.1136/hrt.37.8.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Rosenbaum M. B., Chiale P. A., Halpern M. S., Nau G. J., Przybylski J., Levi R. J., Lázzari J. O., Elizari M. V. Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976 Dec;38(7):934–944. doi: 10.1016/0002-9149(76)90807-9. [DOI] [PubMed] [Google Scholar]
  8. Rosenbaum M. B., Chiale P. A., Ryba D., Elizari M. V. Control of tachyarrhythmias associated with Wolff-Parkinson-White syndrome by amiodarone hydrochloride. Am J Cardiol. 1974 Aug;34(2):215–223. doi: 10.1016/0002-9149(74)90200-8. [DOI] [PubMed] [Google Scholar]
  9. Vérin P., Gendre P., Barchewitz G., Laurent-Bronchat G., Yacoubi M., Morax S. Thésaurismose cornèenne par amiodarone. Données récentes. Arch Ophtalmol Rev Gen Ophtalmol. 1971 Aug-Sep;31(8):581–596. [PubMed] [Google Scholar]
  10. Waleffe A., Bruninx P., Kulbertus H. E. Effects of amiodarone studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. J Electrocardiol. 1978 Jul;11(3):253–260. doi: 10.1016/s0022-0736(78)80125-3. [DOI] [PubMed] [Google Scholar]
  11. Wellens H. J., Durrer D. Effect of procaine amide, quinidine, and ajmaline in the Wolff-Parkinson-White syndrome. Circulation. 1974 Jul;50(1):114–120. doi: 10.1161/01.cir.50.1.114. [DOI] [PubMed] [Google Scholar]
  12. Wellens H. J., Düren D. R., Liem D. L., Lie K. I. Effect of digitalis in patients with paroxysmal atrioventricular nodal tachycardia. Circulation. 1975 Nov;52(5):779–788. doi: 10.1161/01.cir.52.5.779. [DOI] [PubMed] [Google Scholar]
  13. Wellens H. J., Lie K. I., Bär F. W., Wesdorp J. C., Dohmen H. J., Düren D. R., Durrer D. Effect of amiodarone in the Wolff-Parkinson-White syndrome. Am J Cardiol. 1976 Aug;38(2):189–194. doi: 10.1016/0002-9149(76)90148-x. [DOI] [PubMed] [Google Scholar]
  14. Wellens H. J., Tan S. L., Bär F. W., Düren D. R., Lie K. I., Dohmen H. M. Effect of verapamil studied by programmed electrical stimulation of the heart in patients with paroxysmal re-entrant supraventricular tachycardia. Br Heart J. 1977 Oct;39(10):1058–1066. doi: 10.1136/hrt.39.10.1058. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Wu D., Denes P., Dhingra R., Khan A., Rosen K. M. The effects of propranolol on induction of A-V nodal reentrant paroxysmal tachycardia. Circulation. 1974 Oct;50(4):665–677. doi: 10.1161/01.cir.50.4.665. [DOI] [PubMed] [Google Scholar]
  16. Wu D., Wyndham C., Amat-y-Leon F., Denes P., Dhingra R. C., Rosen K. M. The effects of ouabain on induction of atrioventricular nodal re-entrant paroxysmal supraventricular tachycardia. Circulation. 1975 Aug;52(2):201–207. doi: 10.1161/01.cir.52.2.201. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES